Literature DB >> 8621795

Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice.

C L Pummerer1, K Luze, G Grässl, K Bachmaier, F Offner, S K Burrell, D M Lenz, T J Zamborelli, J M Penninger, N Neu.   

Abstract

Immunization with cardiac myosin induces T cell-mediated myocarditis in genetically predisposed mice and serves as a model for autoimmune heart disease. This study was undertaken to identify pathogenic epitopes on the myosin molecule. Our approach was based on the comparison of the pathogenicity between cardiac (alpha-)myosin and soleus muscle (beta-)myosin. We show that alpha-myosin is the immunodominant isoform and induces myocarditis at high severity and prevalence whereas beta-myosin induces little disease. Therefore the immunodominant epitopes of alpha-myosin must reside in regions of different amino acid sequence between alpha- and beta-myosin isoforms. Cardiac myosin peptides corresponding to these regions of difference were synthesized and tested for their ability to induce inflammatory heart disease. Three pathogenic peptides were identified. One peptide that is located in the head portion of the molecule induced severe myocarditis, whereas two others that reside in the rod portion possessed only minor pathogenicity. The identification of pathogenic epitopes on the cardiac myosin molecule will allow detailed studies on the recognition of this antigen by the immune system and might be used to downmodulate ongoing heart disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621795      PMCID: PMC507280          DOI: 10.1172/JCI118642

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis.

Authors:  C Pummerer; P Berger; M Frühwirth; C Ofner; N Neu
Journal:  Lab Invest       Date:  1991-11       Impact factor: 5.662

2.  Characterization of the allelic differences in the mouse cardiac alpha-myosin heavy chain coding sequence.

Authors:  B K Quinn-Laquer; J E Kennedy; S J Wei; K W Beisel
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

Review 3.  Muscle-specific gene expression. A comparison of cardiac and skeletal muscle transcription strategies.

Authors:  V Sartorelli; M Kurabayashi; L Kedes
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

Review 4.  Regulation of myosin heavy chain genes in the heart.

Authors:  E Morkin
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

5.  Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis.

Authors:  S C Smith; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

6.  Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.

Authors:  A L Caforio; M Grazzini; J M Mann; P J Keeling; G F Bottazzo; W J McKenna; S Schiaffino
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

7.  Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes.

Authors:  L Liao; R Sindhwani; L Leinwand; B Diamond; S Factor
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis.

Authors:  A Franco; S Southwood; T Arrhenius; V K Kuchroo; H M Grey; A Sette; G Y Ishioka
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.

Authors:  M H Wauben; C J Boog; R van der Zee; I Joosten; A Schlief; W van Eden
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

10.  Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart.

Authors:  D L Donermeyer; K W Beisel; P M Allen; S C Smith
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  56 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Macrophages participate in IL-17-mediated inflammation.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; Sufey Ong; Farhan Quader; Ping Chen; Dongfeng Zheng; Patrizio Caturegli; Noel R Rose; Daniela Ciháková
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

3.  Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Vahid Khalilzad-Sharghi; Zhongji Han; Shadi Othman; David Steffen; Jay Reddy
Journal:  Int J Cardiol       Date:  2015-09-18       Impact factor: 4.164

4.  Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Authors:  Shouxin Zhang; Xiaoyan Liu; Chengming Sun; Jun Yang; Lihong Wang; Jie Liu; Lei Gong; Yanyan Jing
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

Review 5.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 6.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 7.  Role of impaired central tolerance to α-myosin in inflammatory heart disease.

Authors:  HuiJuan Lv; Myra A Lipes
Journal:  Trends Cardiovasc Med       Date:  2012-08-16       Impact factor: 6.677

8.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

9.  Noninvasive assessment of cardiac abnormalities in experimental autoimmune myocarditis by magnetic resonance microscopy imaging in the mouse.

Authors:  Chandirasegaran Massilamany; Vahid Khalilzad-Sharghi; Arunakumar Gangaplara; David Steffen; Shadi F Othman; Jay Reddy
Journal:  J Vis Exp       Date:  2014-06-20       Impact factor: 1.355

10.  Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice.

Authors:  Patricia A Gonnella; Pedro J Del Nido; Francis X McGowan
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.